038sek
-4,8 %
Date:2026-06-18Time:18:00:00Latest report:Q4-2026List:First NorthTicker:QCORE
Market Cap:16 msekEnterprise Value:11 msekNet Sales:6,74 msekEarnings:-36,5 msekEmployees:0ISIN:SE0016829824

Ratios

10-year key figure history for Qlucore turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Qlucore with index and moving average MA50 and MA200.

Stockprice:0,38
MA50:0,44
MA200:0,47
Price/MA200:-20,1 %
RSI (14):45,4
Price/MA50:-14,3 %

Description

Qlucore develops AI-based software for use in the healthcare sector. The company's precision medicine solutions transform genetic data into decision-making data to create the right treatment for patients. The company's first diagnostic test – for blood cancer in children – has been approved and CE-marked. The company also has tests for lung cancer under development, and is developing the Qlucore Omics Explorer analysis software.

IT Services